Ainos, Inc. (AIMD)

NASDAQ: AIMD · Real-Time Price · USD

4.010

+0.140 (3.62%)

At close: Oct 8, 2025, 4:00 PM EDT

4.070

+0.060 (1.50%)

After-hours: Oct 8, 2025, 7:46 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
Point-of-care Testing, Low-dose Interferon Alpha Therapeutics and Synthetic RNA-driven preventative Medicine	20.73K	Log In	Log In	Log In	Log In	Upgrade
Point-of-care Testing, Low-dose Interferon Alpha Therapeutics and Synthetic RNA-driven preventative Medicine Growth	-83.02%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
United States	20.73K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-83.02%	Log In	Log In	Log In	Log In	Upgrade